Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis
Clinical trial NCT02430909 · COMPLETED
Trial details
- NCT number
- NCT02430909
- Sponsor
- UCB Celltech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-04-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.